Dexcom (DXCM) Net Equity Issued and Repurchased (2010 - 2026)
Dexcom (DXCM) posted Net Equity Issued and Repurchased of $12.7 million for Q1 2026, down 10.6% from $14.2 million a year earlier.
Analysis
Dexcom (DXCM) Net Equity Issued and Repurchased (2010 - 2026) Analysis & Trends
For FY2025, Dexcom's Net Equity Issued and Repurchased came in at $28.1 million, down 0.4% from FY2024.
- Annual Net Equity Issued and Repurchased shows a five-year compound annual growth rate of 12.9% (FY2020 to FY2025).
- In prior years, Dexcom's Net Equity Issued and Repurchased was $28.2 million in FY2024 (+6.0%), $26.6 million in FY2023 (+18.2%), $22.5 million in FY2022 (+10.8%) and $20.3 million in FY2021 (+32.7%).
- The Q1 2026 figure stands as the lowest quarterly Net Equity Issued and Repurchased since Q1 2023.
- On a year-over-year basis, Net Equity Issued and Repurchased increased in two of the last four quarters, with an average decline of 1.8%.
- The strongest year-over-year quarter for Net Equity Issued and Repurchased in the past five years was Q3 2021, with growth of 34.9%; the weakest was Q1 2026, with a decline of 10.6%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 249.71 Bn | 228.86 Bn | 4.88 Bn | - |
| 2 | Abbott Laboratories | 171.00 Bn | 142.08 Bn | 7.27 Bn | 3.00 Mn |
| 3 | Danaher | 155.79 Bn | 139.61 Bn | 3.61 Bn | - |
| 4 | Intuitive Surgical | 143.91 Bn | 123.46 Bn | 1.96 Bn | 65.60 Mn |
| 5 | Medtronic | 110.42 Bn | 76.29 Bn | 6.34 Bn | 20.00 Mn |
| 6 | Stryker | 105.71 Bn | 91.82 Bn | 4.50 Bn | - |
| 7 | Boston Scientific | 63.26 Bn | 58.27 Bn | 3.85 Bn | 5.00 Mn |
| 8 | Edwards Lifesciences | 49.80 Bn | 33.91 Bn | 1.35 Bn | 53.80 Mn |
| 9 | Becton Dickinson | 48.78 Bn | 45.93 Bn | 2.32 Bn | - |
| 10 | Dexcom | 32.57 Bn | 22.88 Bn | 830.00 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 12.70 Mn |
| Sep 30, 2025 | 13.90 Mn |
| Mar 31, 2025 | 14.20 Mn |
| Sep 30, 2024 | 14.80 Mn |
| Mar 31, 2024 | 13.40 Mn |
| Sep 30, 2023 | 14.30 Mn |
| Mar 31, 2023 | 12.30 Mn |
| Sep 30, 2022 | 12.40 Mn |
| Mar 31, 2022 | 10.10 Mn |
| Sep 30, 2021 | 11.60 Mn |
| Mar 31, 2021 | 8.70 Mn |
| Sep 30, 2020 | 8.60 Mn |
| Mar 31, 2020 | 6.70 Mn |
| Sep 30, 2019 | 6.80 Mn |
| Jun 30, 2019 | 100,000.00 |
| Mar 31, 2019 | 5.00 Mn |
| Dec 31, 2018 | 173.20 Mn |
| Sep 30, 2018 | 5.40 Mn |
| Jun 30, 2018 | 1.00 Mn |
| Mar 31, 2018 | 4.20 Mn |
API Access
Dexcom Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=DXCM&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "DXCM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=DXCM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();